Home›Cobicistat›Cobicistat + Nifedipine

Does Cobicistat Interact with Nifedipine?

Cobicistat and Nifedipine have a unknown drug interaction according to U.S. FDA drug labeling data. Calcium Channel Blockers: e.g., amlodipine diltiazem felodipine nifedipine verapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity: Unknown
Cobicistat Class: Cytochrome P450 3A Inhibitor
Nifedipine Class: Dihydropyridine Calcium Channel Blocker
Management: Consult your pharmacist
Data Source: U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Cobicistat and your doctor is considering prescribing Nifedipine (or vice versa), make sure to:

Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
Ask whether the benefits of combining these medications outweigh the risks for your specific situation
Ask what symptoms to watch for that would indicate the interaction is causing problems
Never stop or change either medication without first consulting your healthcare provider

💊 Cobicistat(Tybost)+💊 Nifedipine(Procardia)

Severity & Interaction Details

ℹ️

unknown

Interaction documented — severity unclassified

The FDA label notes an interaction but the severity is not classified in our dataset.

Severity scale

MinorContra

On record

Yes

Drug A class

Cytochrome P450 3A Inhibitor

Drug B class

Dihydropyridine Calcium Channel Blocker

Source

FDA drug label - cobicistat

What this means in plain English

Calcium Channel Blockers: e.g., amlodipine diltiazem felodipine nifedipine verapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.

About Cobicistat and Nifedipine

Cobicistat is a Cytochrome P450 3A Inhibitor, while Nifedipine is a Dihydropyridine Calcium Channel Blocker. You may recognize them by the brand names Tybost and Procardia. Both medications are taken by mouth.

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

PubMed

A precautionary tale of lenacapavir drug-drug interactions: A case series of two persons living with HIV receiving long-acting injections.about Cobicistat · 2026-06

PubMed

Impact on clinical biomarkers, immune recovery, and HIV reservoir dynamics of switching to EVG/c/FTC/TAF versus maintaining a non-INSTI-based regimen in virologically suppressed individuals.about Cobicistat · 2025-10

PubMed

Cystobactamid off-target profiling reveals favorable safety, superoxide reduction, and SCARB1 inhibition in eukaryotes.about Cobicistat · 2025-08

Share this result:

WhatsApp Text / SMS Email

Also share on:X Facebook

Add more drugs

Check Cobicistat and Nifedipine against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.